Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

NCT06442930 · tracked via the Priya Life Science Ireland tracker
Phase
Observational
Started
2025-04-14
Last updated
2026-10-22

Condition(s) studied

Extubation

Study summary

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients (≥18 years old) * Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU * Undergoing extubation during the specified enrollment window Exclusion Criteria: * Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures, * Patients will be excluded if the extubation is performed for tracheostomy decannulation For each patient who is not included, reasons for exclusion will be reported.

Primary outcome measure(s)

  • At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management — Within 60 minutes after the end of extubation
    The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation: i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 \< 80% for \> 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Trial sites (35)

FacilityCityRegionStatus
Banner University Medical Centre Tucson Arizona Completed
University of Arkansas for Medical Sciences Little Rock Arkansas Completed
University of Florida Gainesville Florida Completed
The University of Chicago Chicago Illinois Completed
Oregon Health & Science University Portland Oregon Completed
The University of Texas Health Science Center Houston Texas Completed
Royal North Shore Hospital Sydney New South Wales Completed
The Northern Hospital Melbourne Victoria Completed
Austin Health - Heidelberg Repatriation Hospital Melbourne Victoria Completed
Austin Health - Austin Hospital Melbourne Victoria Completed
Eastern Health - Box Hill Hospital Melbourne Victoria Completed
Eastern Health - Maroondah Hospital Melbourne Victoria Completed
Eastern Health - Angliss Hospital Melbourne Victoria Completed
Surrey Memorial Hospital Surrey British Columbia Completed
The Moncton Hospital Moncton New Brunswick Completed
Sunnybrook Hospital North York Ontario Completed
Niagara Health - Marotta Family Hospital Saint Catharines Ontario Completed
St. Michael's Hospital Toronto Ontario Completed
Mount Sinai Hospital Toronto Ontario Completed
University Health Network - Toronto General Hospital Toronto Ontario Recruiting
University Health Network - Toronto Western Hospital Toronto Ontario Completed
Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec Completed
Hospital Internacional de Colombia Piedecuesta Colombia Completed
Mayo University Hospital Castlebar Ireland Completed
Cork University Hospital Cork Ireland Completed
Mater Misericordiae University Hospital Dublin Ireland Completed
Galway University Hospitals Galway Ireland Completed
University Hospital Waterford Waterford Ireland Not Yet Recruiting
Amiri Hospital Kuwait City Kuwait Completed
Auckland City Hospital Auckland New Zealand Completed
Southland Hospital Invercargill New Zealand Completed
Rotorua Hospital Rotorua New Zealand Completed
Tan Tock Seng Hospital Singapore Singapore Completed
Royal United Hospitals Bath Bath United Kingdom Completed
Freeman Hospital Newcastle upon Tyne United Kingdom Completed
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06442930 on ClinicalTrials.gov ↗ ← All trials in Ireland